Could the FDA-approved anti-HIV PR inhibitors be promising anticancer agents? An answer from enhanced docking approach and molecular dynamics analyses

Por Arodola, Olayide A, Soliman, Mahmoud ES
Publicado no Drug Des Devel Ther (2015)

Quantum mechanics implementation in drug-design workflows: does it really help?

Por Arodola, Olayide A, Soliman, Mahmoud ES
Publicado no Drug Des Devel Ther (2017)

Per-residue energy decomposition pharmacophore model to enhance virtual screening in drug discovery: a study for identification of reverse transcriptase inhibitors as potential ant...

Por Cele, Favourite N, Ramesh, Muthusamy, Soliman, Mahmoud ES
Publicado no Drug Des Devel Ther (2016)

Using bioinformatics tools for the discovery of Dengue RNA-dependent RNA polymerase inhibitors

Por Nncube, Nomagugu B., Ramharack, Pritika, Soliman, Mahmoud E.S.
Publicado no PeerJ (2018)

Molecular modelling studies of synthesized pentacyclo-undecane peptides as potential HIV-1 wild type C-SA protease inhibitors

Por Honarparvar, Bahareh, Kruger, Hendrik G, Soliman, Mahmoud ES, Maguire, Glenn EM, Govender, Thavendran
Publicado em 2013